Why I’d buy gold stock Randgold Resources Limited in 2018

With plenty of cash, Randgold Resources Limited (LON: RRS) could be the perfect hedge against uncertainty.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Over the last few days, gold has proven itself as an excellent hedge for investors against market turbulence. 

While stock markets around the world have taken a tumble following concerns about rising US inflation and bond yields, the price of gold has remained relatively unchanged and has certainly not seen the same type of volatility as equities. 

Unfortunately, owning gold directly can be a complicated and expensive business, which is why gold mining stocks tend to be a better buy for investors. Randgold Resources (LSE: RRS) is in my view one of the sector’s best bets. 

From strength to strength 

Today the company announced that for the seventh year in a row, it has managed to increase its gold production. Output for the year to the end of December increased by 5% to 1.315m ounces while the total cash cost of each ounce mined decreased by 3% to $620. 

Thanks to a higher average gold price throughout the year, total profit for the period rose 14% to $335m with the group’s overall net cash on the balance sheet rising 39% to $720m (along with  the current market capitalisation of £6.6bn). With this sizeable financial cushion in place, management has decided to double the full-year dividend to $2 per share (or around 1.4p). 

A gold proxy 

The investment thesis for Randgold is simple. The shares offer a proxy on the price of gold. Operational gearing means the firm’s investors will profit substantially if the price of gold moves suddenly higher, and unlike owning the commodity directly, rather than having to pay to store gold, the shares currently support a dividend yield of 2%. This isn’t much, but considering the annual charge for storing gold could be as high as 1%, it makes a big difference. 

Randgold’s smaller peer Centamin (LSE: CEY) has all the same qualities as its larger sector peer but is a cheaper investment. Compared to Randgold, which currently trades at a forward P/E of 27, shares in Centamin trade at a forward earnings multiple of only 18. The stock also supports a much higher dividend yield of 4.1%, which once again, when compared to the 1% usually charged to store physical gold, looks to be a high return (it is around 0.9% above the market average dividend yield as well). 

The stock’s low valuation can be attributed in part to Centamin’s poor performance for fiscal 2017. Thanks to higher than expected fuel costs, its all-in sustaining cost of producing an ounce of gold rose 14% during the period. These higher costs resulted in a 13% fall in core profit.

Still, Centamin is run conservatively, and management has been using the rising gold price to fortify its balance sheet. At the end of fiscal 2017, the company had a net cash balance of $360m, which works out at around 14% of the firm’s overall market capitalisation. 

Time to get defensive 

Gold is one of the world’s most defensive assets, and as a result, gold miners are themselves a great defensive play. As I’ve written before, due to rising global geopolitical and economic uncertainty, I believe gold is an excellent hedge against risk in 2018. Both Centamin and Randgold offer the same kind of hedge with the added bonus of dividend income.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

Here’s why H1 results could boost the AstraZeneca share price

The AstraZeneca share price has been a success story in the past five years. With H1 results due, can it…

Read more »

Investing Articles

£17,365 in savings? Here’s how I’d use it to target a £6,700-a-month passive income

Here's how a lump sum investment could pave the way for me to make a four-figure monthly passive income in…

Read more »

Investing Articles

Down more than 10% in 6 months, Fools are backing these 5 UK stocks to reverse that – and then some! – by 2025

Some of our UK free-site writers have put forward their candidates for turnaround stocks!

Read more »

Investing Articles

Down 23%! Should I buy more CrowdStrike shares for my Stocks and Shares ISA?

Sometimes bad news can be good news for long-term investors. But is that the case for CrowdStrike in relation to…

Read more »

Investing Articles

2 UK shares near 52-week lows I’m considering snapping up

These UK shares are loitering near, or at, 52-week lows. Are these prime opportunities for our writer to boost her…

Read more »